Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coronavirus disease 2019 (COVID‐19) update: From metabolic reprogramming to immunometabolism
Mohammad Rudiansyah, Saade Abdalkareem Jasim, Zeinab Gol Mohammad pour, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4611-4627
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Muribaculum intestinale-derived 3-hydroxybutyric acid from Heterophyllin B attenuated pulmonary fibrosis through IDO1-mediated ferroptosis
Ce Chen, Jialin Wang, Ming Cheng, et al.
Pharmacological Research (2025) Vol. 212, pp. 107587-107587
Open Access | Times Cited: 1
Deciphering the Relationship between SARS-CoV-2 and Cancer
Michele Costanzo, Maria Anna Rachele De Giglio, Giovanni N. Roviello
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7803-7803
Open Access | Times Cited: 22
Chili pepper: A delve into its nutritional values and roles in food-based therapy
Ayman Faris Faisal, Yasser Fakri Mustafa
Food Chemistry Advances (2025) Vol. 6, pp. 100928-100928
Closed Access
Cellular metabolism hijacked by viruses for immunoevasion: potential antiviral targets
Jiaqi Li, Yanjin Wang, Hao Deng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Synthesis of novel 6-aminocoumarin derivatives as potential –biocompatible antimicrobial and anticancer agents
Yasser Fakri Mustafa
Journal of Molecular Structure (2024) Vol. 1320, pp. 139658-139658
Closed Access | Times Cited: 4
A systematic review on impact of SARS-CoV-2 infection
Thirumugam Gowripriya, Yashwanth Radhakrishnan, Suresh Ramamurthi, et al.
Microbiological Research (2023) Vol. 271, pp. 127364-127364
Open Access | Times Cited: 8
PoRVA G9P[23] and G5P[7] infections differentially promote PEDV replication by reprogramming glutamine metabolism
Haixin Liu, Haolun Tian, Pengcheng Hao, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 6, pp. e1012305-e1012305
Open Access | Times Cited: 2
Role of different types of RNA molecules in the severity prediction of SARS-CoV-2 patients
Pratheeba Jeyananthan
Pathology - Research and Practice (2023) Vol. 242, pp. 154311-154311
Open Access | Times Cited: 7
Reprogramming the tumor microenvironment to improve the efficacy of cancer immunotherapies
Jabar A. Faraj, Ali Jihad Hemid Al-Athari, Sharaf El Din Mohie, et al.
Medical Oncology (2022) Vol. 39, Iss. 12
Open Access | Times Cited: 10
Shortening the long-COVID: An exploratory review on the potential of Unani medicines in mitigating post-Covid-19 sequelae
Sadia Nikhat, Mohammad Fazil
Phytomedicine Plus (2024) Vol. 4, Iss. 2, pp. 100570-100570
Open Access | Times Cited: 1
Unlocking the therapeutic potential of edible mushrooms: Ganoderma and their secondary metabolites as novel antiviral agents for combating COVID-19
Samantha C. Karunarathna, Wenhua Lu, Nimesha Patabedige, et al.
New Zealand Journal of Botany (2024), pp. 1-59
Closed Access | Times Cited: 1
COVIDomics: Metabolomic Views on COVID-19
Armando Cevenini, Lucia Santorelli, Michele Costanzo
Metabolites (2024) Vol. 14, Iss. 12, pp. 702-702
Open Access | Times Cited: 1
High Risk of Heart Tumors after COVID-19
Л. Б. Митрофанова, I. A. Makarov, Э. А. Гончарова, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2087-2087
Open Access | Times Cited: 4
Traumatic Brain Injury in the Long-COVID Era
Denes V. Agoston
Neurotrauma Reports (2024) Vol. 5, Iss. 1, pp. 81-94
Open Access | Times Cited: 1
Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohort
Mario Karolyi, Andreas Gruebl, Sara Omid, et al.
Infection (2022) Vol. 51, Iss. 4, pp. 851-858
Open Access | Times Cited: 6
Potential biocide roles of violacein
Ignacio Rivero Berti, Melisa E. Gantner, Santiago Rodrı́guez, et al.
Frontiers in Nanotechnology (2023) Vol. 5
Open Access | Times Cited: 3

Qassim A. Zigam, Adeeb A. Al-Zubaidy, Zahraa Sami, et al.
Journal of Medicinal and Chemical Sciences (2022) Vol. 6, Iss. 3
Open Access | Times Cited: 5
Regulation of a Metabolic Gene Signature in Response to Respiratory Viruses and Type I Interferon Signaling
Chilakamarti V. Ramana
Journal of Molecular Pathology (2024) Vol. 5, Iss. 1, pp. 133-152
Open Access
Regulation of lipid and serine metabolism by the oncogene c-Myc
Subhajit Chatterjee, Prarthana Prashanth, Vipin Rawat, et al.
International review of cell and molecular biology (2024), pp. 236-256
Closed Access
Coumarin Backbone as a Door-Opening Key for Investigating Chloroxylenol as Oral Antimicrobial Agents: an In Vitro–In Silico Study
Atyaf Talal Mahmood, Islam Kamal, Yasser Fakri Mustafa
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 6, pp. 2252-2268
Closed Access
Decoding NAD+ Metabolism in COVID-19: Implications for Immune Modulation and Therapy
Shixu Song, Jianhong Gan, Qiuyue Long, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 1-1
Open Access
Exploring the role of tryptophanyl-tRNA synthetase and associations with inflammatory markers and clinical outcomes in COVID-19 patients: A case-control study
Nastaran Najimi, Hamid Zahednasab, Mohammad Farahmand, et al.
Microbial Pathogenesis (2023) Vol. 183, pp. 106300-106300
Closed Access | Times Cited: 1

Tayseer Shamran Al-Deresawi, Melad Khalaf Mohammed, Saad Hussein Khudhair
Journal of Medicinal and Chemical Sciences (2022) Vol. 6, Iss. 3
Open Access | Times Cited: 2
COVID-19 vaccination in patients with cancer: Opportunities and challenges
Zahraa Haleem Al‐qaim, Hasanain Kamil Hasan Owadh, Sarah A. Ali, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top